26 related articles for article (PubMed ID: 1416028)
1. Binding Chromium(III) to Form Mixed Cr(III),Fe(III) Serum Transferrins.
Graham DR; Drummond E; Barrido M; Vincent JB
Biol Trace Elem Res; 2024 Jul; 202(7):3377-3382. PubMed ID: 37943387
[TBL] [Abstract][Full Text] [Related]
2. Holo/apo conversion two-dimensional urea PAGE for speciation of Fe
Saito S; Ishikawa J; Ono M; Tasaki-Handa Y; Shibukawa M
Anal Sci; 2024 Feb; 40(2):227-233. PubMed ID: 37966577
[TBL] [Abstract][Full Text] [Related]
3. Urea Gel Electrophoresis in Studies of Conformational Changes of Transferrin on Binding and Transport of Non-Ferric Metal Ions.
Levina A; Wang B; Lay PA
Gels; 2021 Dec; 8(1):. PubMed ID: 35049554
[TBL] [Abstract][Full Text] [Related]
4. Human serum transferrin fibrils: nanomineralisation in bacteria and destruction of red blood cells.
Mukherjee A; Barnett MA; Venkatesh V; Verma S; Sadler PJ
Chembiochem; 2015 Jan; 16(1):149-55. PubMed ID: 25476866
[TBL] [Abstract][Full Text] [Related]
5. Reinforcing Protein Biochemistry: A Two-Week Experiment Studying Iron(III) Binding by the Transferrin Protein through Stoichiometric Determination, Stability Analysis, and Visualization of the Binding Site.
BenjamÃn-Rivera JA; Otero MP; Tinoco AD
J Chem Educ; 2024 Apr; 101(4):1656-1664. PubMed ID: 38654892
[TBL] [Abstract][Full Text] [Related]
6. Growth of human tumor cell lines in transferrin-free, low-iron medium.
Neumannova V; Richardson DR; Kriegerbeckova K; Kovar J
In Vitro Cell Dev Biol Anim; 1995 Sep; 31(8):625-32. PubMed ID: 8528518
[TBL] [Abstract][Full Text] [Related]
7. Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications.
Sirbasku DA; Moreno-Cuevas JE
In Vitro Cell Dev Biol Anim; 2000; 36(7):428-46. PubMed ID: 11039494
[TBL] [Abstract][Full Text] [Related]
8. Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.
Moreno-Cuevas JE; Sirbasku DA
In Vitro Cell Dev Biol Anim; 2000; 36(7):410-27. PubMed ID: 11039493
[TBL] [Abstract][Full Text] [Related]
9. Anion binding properties of the transferrins. Implications for function.
Harris WR
Biochim Biophys Acta; 2012 Mar; 1820(3):348-61. PubMed ID: 21846492
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone regulation of rat pituitary tumor cell growth: a new role for apotransferrin as an autocrine thyromedin.
Sirbasku DA; Pakala R; Sato H; Eby JE
Mol Cell Endocrinol; 1991 May; 77(1-3):C47-55. PubMed ID: 1815990
[TBL] [Abstract][Full Text] [Related]
11. Preparation of iron-deficient tissue culture medium by deferoxamine-sepharose treatment and application to the differential actions of apotransferrin and diferric transferrin.
Eby JE; Sato H; Sirbasku DA
Anal Biochem; 1992 Jun; 203(2):317-25. PubMed ID: 1416028
[TBL] [Abstract][Full Text] [Related]
12. Apotransferrin stimulation of thyroid hormone dependent rat pituitary tumor cell growth in serum-free chemically defined medium: role of FE(III) chelation.
Eby JE; Sato H; Sirbasku DA
J Cell Physiol; 1993 Sep; 156(3):588-600. PubMed ID: 8360262
[TBL] [Abstract][Full Text] [Related]
13. Apotransferrins from several species promote thyroid hormone-dependent rat pituitary tumor cell growth in iron-restricted serum-free defined culture.
Sato H; Eby JE; Pakala R; Sirbasku DA
Mol Cell Endocrinol; 1992 Feb; 83(2-3):239-51. PubMed ID: 1547914
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone dependent pituitary tumor cell growth in serum-free chemically defined culture. A new regulatory role for apotransferrin.
Sirbasku DA; Pakala R; Sato H; Eby JE
Biochemistry; 1991 Jul; 30(30):7466-77. PubMed ID: 1854748
[TBL] [Abstract][Full Text] [Related]
15. Purification of an equine apotransferrin variant (thyromedin) essential for thyroid hormone dependent growth of GH1 rat pituitary tumor cells in chemically defined culture.
Sirbasku DA; Stewart BH; Pakala R; Eby JE; Sato H; Roscoe JM
Biochemistry; 1991 Jan; 30(1):295-304. PubMed ID: 1988026
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
